This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Bruce E. Carlson, MD; Robert L. Sadoff, MD
Norristown, Pa

JAMA. 1971;217(12):1705.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

At Norristown (Pa) State Hospital, we have had considerable experience in the use of thioridazine (Mellaril), primarily with schizophrenics, but also with patients with nonpsychotic severe anxiety reactions. It is well known that thioridazine, because of its adrenolytic activity, inhibits or prevents ejaculation in some patients. Though not specifically dose-related, this phenomenon is generally more severe at higher dosages.

Thioridazine has been shown to cause impotency in males and delay of orgasm in both men and women. Occasionally, thioridazine has been found to be effective in the treatment of premature ejaculation, prolonging the time between insertion and ejaculation. The exact basis of this effect is unknown but may be related to decrease in anxiety or a specific chemical effect on the sexual functioning.

Schizophrenics, generally, are most disturbed by any changes in bodily function, whatever the cause, but especially in their sexual functioning. With the use of . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?